ERVW-1 and hepatocellular carcinoma: Rapidly emerging evidence indicates that increased ERVWE1 activity has been suggested in several disease, including MS [6], urothelial cell carcinoma of the bladder (UCC) [9], hepatocellular carcinoma (HCC) [10], type 1 diabetes [11], and schizophrenia [12,13,14,15,16].